Concannon KF, Glisson BS, Doebele RC, Huang C, et al. A Phase I Open-Label Study of Cediranib Plus Etoposide and Cisplatin as First-Line Therapy for Patients With Extensive-Stage Small-Cell Lung Cancer or Metastatic Neuroendocrine Non-Small-Cell Lung Cancer. Clin Lung Cancer 2024 Sep 1:S1525-7304(24)00193.
PMID: 39307607